Haemonetics Corporation

Haemonetics is THE Blood Management Company. Our comprehensive portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood management continuum. Collectively they help improve patient care, ensure patient safety, and reduce costs for blood and plasma collectors, hospitals, and patients around the world. Our Mission We believe that through proper blood management, our products and services can help our commercial plasma and blood center customers optimize their collection processes. We seek to help ensure a continual supply of high-quality plasma for biopharmaceuticals and blood components for therapeutic use at optimal costs, along with better blood management processes. Working with our hospital customers, we seek to prevent a blood transfusion to the patient who doesn’t need one, or, if a transfusion is necessary, to ensure the transfusion of the right blood product, at the right time, in the right dose to the patient who does.
Company Growth (employees)
Type
Public
HQ
Braintree, US
Founded
1971
Size (employees)
3,225 (est)
Haemonetics Corporation was founded in 1971 and is headquartered in Braintree, US

Haemonetics Corporation Office Locations

Haemonetics Corporation has offices in Braintree, Beirut, Tijuana, Chiyoda and in 10 other locations
Braintree, US (HQ)
400 Wood Rd
Wenshan District, TW
2 Section 6, Roosevelt Rd
Bengaluru, IN
104 Epip Zone Whitefield Rd
Macquarie Park, AU
Level 2, Everglade Campus 82 Waterloo Rd
Vancouver, CA
1099 W 8th Ave
Edmonton, CA
500 Td Tower 10025 102 A Ave Nw
Gingins, CH
Rlle Du Ctre

Haemonetics Corporation Data and Metrics

Haemonetics Corporation Financial Metrics

Haemonetics Corporation's revenue was reported to be $908.8 m in FY, 2016 which is a 0% decrease from the previous period.
Numbers are in $, USD

Revenue (FY, 2016)

908.8 m

Revenue growth (FY, 2015 - FY, 2016), %

(0%)

Gross profit (FY, 2016)

405.9 m

Gross profit margin (FY, 2016), %

45%

Net income (FY, 2016)

(55.6 m)

EBIT (FY, 2016)

(43.9 m)

Market capitalization (26-May-2017)

2.1 b

Closing share price (26-May-2017)

40.9

Cash (31-Dec-2016)

115.1 m

EV

2.4 b
Haemonetics Corporation's current market capitalization is $2.1 b.
Numbers are in $, USDFY, 2014FY, 2015FY, 2016

Revenue

938.5 m910.4 m908.8 m

Revenue growth, %

(3%)(0%)

Cost of goods sold

470.1 m476 m502.9 m

Gross profit

468.4 m434.4 m405.9 m

Gross profit Margin, %

50%48%45%

R&D expense

54.2 m54.2 m45 m

General and administrative expense

366 m337.2 m317.2 m

Operating expense total

449.9 m393.9 m449.9 m

EBIT

46.4 m40.5 m(43.9 m)

EBIT margin, %

5%4%(5%)

Net Income

35.1 m16.9 m(55.6 m)
Numbers are in $, USDFY, 2014FY, 2015FY, 2016

Cash

192.5 m160.7 m115.1 m

Inventories

54.1 m40.1 m28.8 m

Current Assets

623 m570.3 m488.1 m

PP&E

271.4 m321.9 m337.6 m

Goodwill

336.8 m334.3 m267.8 m

Total Assets

1.5 b1.5 b1.3 b

Accounts Payable

53.6 m48.4 m39.7 m

Total Debt

437.7 m427.9 m408 m

Current Liabilities

216.9 m189.1 m185.6 m

Additional Paid-in Capital

402.6 m427 m439.9 m

Retained Earnings

433.3 m420.4 m316.2 m

Total Equity

837.9 m826.1 m721.6 m

Debt to Equity Ratio

0.5 x0.5 x0.6 x

Debt to Assets Ratio

0.3 x0.3 x0.3 x

Financial Leverage

1.8 x1.8 x1.8 x
Numbers are in $, USDFY, 2014FY, 2015FY, 2016

Net Income

35.1 m16.9 m(55.6 m)

Depreciation and Amortization

81.7 m86.1 m89.9 m

Accounts Receivable

6.1 m8.4 m(10.3 m)

Inventories

(13 m)(17 m)11.9 m

Accounts Payable

477 k2 m(30.2 m)

Cash From Operating Activities

139.5 m127.2 m121.9 m

Capital Expenditures

(73.6 m)(122.2 m)(102.4 m)

Cash From Investing Activities

(105.8 m)(121.8 m)(104.8 m)

Long-term Borrowings

(37.1 m)(8.5 m)(21.3 m)

Cash From Financing Activities

(20.7 m)(33.2 m)(62.6 m)

Interest Paid

8.9 m8.5 m8.5 m

Income Taxes Paid

1.5 m11.2 m7.8 m

Free Cash Flow

65.9 m5 m19.5 m
Numbers are in $, USDY, 2016

EV/EBIT

-55.4 x

EV/CFO

20 x

EV/FCF

125 x

Revenue/Employee

268.6 k

Debt/Equity

0.6 x

Debt/Assets

0.3 x

Financial Leverage

1.8 x

Haemonetics Corporation Operating Metrics

FY, 2016

Facilities

8

Haemonetics Corporation Market Value History

Haemonetics Corporation Revenue Breakdown

Haemonetics Corporation Median Salaries

Source: 21 public H-1B filings from Haemonetics Corporation

Haemonetics Corporation Online and Social Media Presence

Haemonetics Corporation Company Life and Culture

You may also be interested in